Banff 2022 Liver Group Meeting report: Monitoring long-term allograft health.
Bellamy COC, O'Leary JG, Adeyi O, Baddour N, Batal I, Bucuvalas J, Del Bello A, El Hag M, El-Monayeri M, Farris AB 3rd, Feng S, Fiel MI, Fischer SE, Fung J, Grzyb K, Guimei M, Haga H, Hart J, Jackson AM, Jaeckel E, Khurram NA, Knechtle SJ, Lesniak D, Levitsky J, McCaughan G, McKenzie C, Mescoli C, Miquel R, Minervini MI, Nasser IA, Neil D, O'Neil MF, Pappo O, Randhawa P, Ruiz P, Fueyo AS, Schady D, Schiano T, Sebagh M, Smith M, Stevenson HL, Taner T, Taubert R, Thung S, Trunecka P, Wang HL, Wood-Trageser M, Yilmaz F, Zen Y, Zeevi A, Demetris AJ.
Bellamy COC, et al. Among authors: feng s.
Am J Transplant. 2024 Mar 9:S1600-6135(24)00204-1. doi: 10.1016/j.ajt.2024.03.008. Online ahead of print.
Am J Transplant. 2024.
PMID: 38461883
Free article.
Presentations and discussions focused on the evaluation of long-term allograft health, including noninvasive and tissue monitoring, immunosuppression optimization, and long-term structural changes. Potential revision of the rejection classification scheme to better …
Presentations and discussions focused on the evaluation of long-term allograft health, including noninvasive and tissue monitoring, i …